ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Gap Up – Here’s What Happened

ChronoScale Corporation Common Stock (NASDAQ:CHRN) shares gapped up before the market opened on Monday. The stock had previously closed at $14.38, but opened at $15.16. ChronoScale Corporation Common Stock shares last traded at $14.28, with a volume of 12,966 shares.

Analyst Ratings Changes

A number of equities analysts have issued reports on CHRN shares. Northland Securities initiated coverage on ChronoScale Corporation Common Stock in a report on Friday, September 18th. They set an “outperform” rating and a $32.00 target price for the company. Compass Point initiated coverage on ChronoScale Corporation Common Stock in a research note on Friday, October 16th. They issued a “buy” rating and a $25.00 price target for the company. Finally, Weiss Ratings cut ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a report on Friday, October 23rd. Two analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $21.00.

ChronoScale Corporation Common Stock Stock Performance

The company has a quick ratio of 0.30, a current ratio of 0.30 and a debt-to-equity ratio of 0.02. The stock has a 50 day moving average of $18.22 and a 200 day moving average of $16.02. The company has a market capitalization of $1.99 billion, a price-to-earnings ratio of -3.17 and a beta of 1.12.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last released its earnings results on Wednesday, October 14th. The company reported ($0.29) earnings per share (EPS) for the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 66.16%. The company had revenue of $41.48 million for the quarter. As a group, analysts predict that ChronoScale Corporation Common Stock will post -0.49 EPS for the current year.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.